Happy #PiDay! 🥧🎉 We're celebrating 3.14 with our annual tradition — enjoying some delicious pie and recognizing the importance of π in our science and innovation.

MOMA's office was designed with intention — conference rooms honor scientists, including groundbreaking women. Each room is a tribute to their achievements, inspiring innovation & curiosity, especially during #WomensHistoryMonth. Learn more about some of them below!

MOMA’s Senior Director of Informatics & Technology, Kate Hardy will join other industry experts for a discussion on data-centric automation in biopharma R&D at this year’s Genedata Partner Symposium in Boston! Catch the panel conversation Tue, April 1. genedata.com/2025-genedata-…

We're pleased to announce Susan Pandya, M.D. has joined as an independent board of directors member w/ ~20 yrs of experience in #oncology #drugdevelopment. We look forward to her guidance as we advance our portfolio. Welcome to the team! Read more: businesswire.com/news/home/2025…

MOMAtes were happy to have newly appointed independent board member, Susan Pandya, M.D., in the office & get to know her better through a fireside chat w/ CEO, Asit Parikh. She shared valuable insights from her experience – we’re excited to have her expertise guiding our mission.

We are thrilled to welcome Neil Lineberry, Ph.D., to the MOMA team as head of corporate development! W/ 20+ years in life sciences, including leadership at Takeda, Neil brings deep expertise in strategy, investor relations, business development and oncology clinical development.

Last week, we welcomed Aaron Conley back to MOMA to share his experience with stage three #coloncancer and treatment. His resilience, advocacy, and work in biomedical philanthropy continue to inspire us. Thank you, Aaron, for your dedication to research and patient support!

Today, MOMA turns 5! That’s half a decade of courageous acts, science w/ purpose, success together, & serious joy in our work (& each other). From launch, MOMAtes have built bold ideas & fueled our progress in #drugdiscovery. Here’s to the people, the purpose, & what’s ahead.

Jessica Russo, Strategic Director, DEI, Louise Santosuosso, VP, Development, & Sara Riffel, Director, Corporate Affairs from American Cancer Society Society visited MOMA for an open discussion on cancer disparities & the central place equity in #cancercare for all plays in their mission.

We're pleased to share upcoming poster presentations @ #AACR25! Jordan Krall, Ph.D., Allison Drew & Amita Patnaik, M.D. will each share recent research and progress w/ the #oncology community in Chicago next week. Read more about the posters: businesswire.com/news/home/2025…

Congrats to MOMAte, Kayla Duval, on completing the Boston Marathon! Kayla’s dedication to fundraising is just as strong as her dedication to her work @ MOMA as a Scientist. We’re proud of her not only for this major accomplishment, but for raising $10k for Mass General Hospital.

We’re back from #AACR2025 and energized by the conversations, connections, and science our team shared. Check out the three posters we presented at the conference in our newsroom → momatx.com/news-feed/

Last night, we were proud to close out #AAPIHeritageMonth as a sponsor of AsianWomenForHealth’s CelebrAsians Gala. Special shoutout to MOMA’s own Adam Thomas for his board work as co-chair, advancing their mission to uplift Asian women’s health & well-being.

In honor of #NCSD2025, MOMAtes joined American Cancer Society’s Hope Lodge to #CelebrateLife and support cancer patients & caregivers with a comforting taco night. We’re proud to lend a hand to a place that offers a free home during treatment for patients and caregivers during treatment.

It was great to host members of Sisters in STEM from Duke University last week! They toured our labs, learned about biotech careers, and connected with MOMAtes, including a proud Duke alum. Grateful for the visit and the inspiring conversation. We can't wait to see where these women go.

MOMAte Anthony Tubbs will present a poster on TA repeat expansion outperforming MSI-H as a predictor of sensitivity to the novel WRN inhibitor, MOMA-341, @ the 2nd Balancing Genome Fidelity & Plasticity Conference in Lisbon next week. Check it out: fusion-conferences.com/conference/174…

Greetings from Lisbon! This week, MOMA’s Anthony Tubbs presented at the 2nd Balancing Genome Fidelity & Plasticity Conference, where he highlighted our latest work on MOMA-341, our novel WRN inhibitor.

We're pleased to share that we’ve dosed the first patient in the Phase 1 trial of MOMA-341, a potent oral Werner helicase inhibitor discovered with our KNOMATIC™ platform, for advanced MSI-H/dMMR tumors. Read more: businesswire.com/news/home/2025…

Last Friday, we hosted our annual MOMA Family Field Day, one of our favorite traditions that brings our team and their families together for some well-deserved fun! We had bounce houses, relay races, and hands-on science for the kids to bring joy all around.

On Wednesday, MOMAte Meredeth McGowan will share the story of MOMA-341’s discovery with the greater #chemistry community at the ACS Fall 2025 in Washington, D.C.  For details check out:  acs.org/events/fall.ht…